CYDY Message Board Post 8969918 | CytoDyn Inc
home / stock / cydy / cydy message board
Soupy
(investorshub)
Posted on: Apr/27/2023 16:17:57
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171787114
https://www.cell.com/neuron/fulltext/S0896-6273(23)00268-4?_returnURL=https%3A%2F%2Flinkinghub.elsev
News, Short Squeeze, Breakout and More Instantly...
-
Terms of the settlement include $12,000,000 cash payment to CytoDyn and elimination of $14,000,000 accounts payable liability from the Company’s balance sheet VANCOUVER, Washington, July 09, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a bio...
-
VANCOUVER, Washington, June 27, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that its preclinical MASH study with SMC ...
-
VANCOUVER, Washington, May 28, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Dr. Jacob P. Lalezari, Chief Executiv...